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ABSTRACT 
 
BLOOD EOSINOPHILS AND SERUM IgE LEVELS AS BIOMARKERS IN 
RESPONSE TO INHALED CORTICOSTEROIDS IN COPD 
 
BACKGROUND: 
Airway eosinophilia, hallmark feature of Asthma, is now a recognized inflammatory pattern 
in COPD. In 10–40% of COPD, eosinophilic airway inflammation has been reported. 
Smoking (nicotine), a risk factor promotes allergic reactions which cause elevated IgE levels. 
  
OBJECTIVES: 
1.To identify COPD exacerbations associated with elevated blood eosinophils 
2.To correlate elevated blood eosinophils and serum IgE levels with exacerbation of COPD 
 
METHODOLOGY: 
140 COPD patients were studied prospectively for a period of 1 year (Aug 2016 to Aug 2017) 
in GHTM, Tambaram. Patients with clinical diagnosis of COPD and post-bronchodilator 
FEV1/FVC ratio of less than 0.7 as per GOLD criteria considered. Based on 
ANTHONISEN’S criteria classified as stable COPD & COPD exacerbation. Peripheral blood 
collected for Absolute Eosinophil Count (AEC) & Serum IgE.                                                
 
RESULTS:                                                                                                                                                         
 
Among 140 COPD patients, Males-119(85%), Females-21(15%) were between 45-75 years 
of age group. COPD population belonging to GOLD I,GOLD II,GOLD III,GOLD IV staging 
were 21(15%), 40(28.5%), 58(41.4%), 21(15%) respectively. Of which, stable COPD were 
53 (37.8%) & COPD exacerbations 87(62%). The AEC in stable COPD (468.9) & COPD 
exacerbation (890.8) while, Serum IgE in stable COPD (1289.5) & COPD exacerbation 
(2309) was observed. Current smokers showed elevated AEC (747) & Serum IgE levels 
(2214) compared to nonsmokers with AEC (660) & Serum IgE (646) respectively. 
                                                                                                                                                                    
 
CONCLUSION: 
AEC & Serum IgE levels can be considered as biomarkers of COPD exacerbations that allow 
identification of patients who most likely respond to ICS. 
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